患者与提供者助推对带状疱疹疫苗系列完成的影响
本研究评估提供者层面助推与短信患者助推对带状疱疹疫苗系列完成的影响。基线期100627名成人中83.9%在6个月内完成系列,平均间隔88.6天;干预期120339名成人中,同时接受两种助推者完成率88.3%,未接受短信者85.3%(均p<0.0001);控制多种特征后,干预期完成比值较基线提高(OR 1.07;95%CI 1.033-1.111),接受短信者完成比值更高(OR 1.35;95%CI 1.286-1.414),且第二剂提前8.6天(95%CI -9.08至-8.17,p<0.0001)。
要点
- 干预期接受短信者完成率88.3%,未接受短信者85.3%,均p<0.0001。
- 控制特征后,接受短信者完成比值OR 1.35(95%CI 1.286-1.414)。
- 接受短信者第二剂较仅提供者助推者提前8.6天(95%CI -9.08至-8.17)。
核心结论
- 临床与患者层面助推联合使用是药房等医疗接入点满足多元人群多剂疫苗需求的简单机制。
研究设计与样本
- 在Kroger Health实施提供者层面助推后,选取已启动带状疱疹疫苗接种的美国患者随机接受定时短信(第二剂到期时),作为质量改进项目。
- 主要比较仅接受提供者助推的患者与同时接受提供者和患者助推的患者。
- 数据分析采用基于GEE的logistic和线性回归,控制可用的患者和门店特征,并进行地理空间分析。
主要发现
- 基线期100627名成人至少接种一剂带状疱疹疫苗,83.9%在6个月内完成系列,平均间隔88.6天(SD 26.53)。
- 干预期120339名成人至少接种一剂,系列完成率88.3%(同时接受提供者助推和短信)和85.3%(未接受短信),均p<0.0001。
- 接受短信者两剂间隔较基线期和干预期未接受短信者均更短(均p<0.001)。
- 控制多种特征后,干预期完成比值较基线提高(OR 1.07;95%CI 1.033-1.111),接受短信者完成比值更高(OR 1.35;95%CI 1.286-1.414)。
- 调整患者和药房因素后,接受短信者第二剂较仅提供者助推者提前8.6天(95%CI -9.08至-8.17,p<0.0001)。
临床怎么用
- 原文结论指出,临床与患者层面助推联合使用是药房等医疗接入点满足多元人群多剂疫苗需求的简单机制。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the combined impact of provider-facing and text message-based, patient nudges on herpes zoster vaccine series completion. METHODS: Following a period during which Kroger Health implemented provider facing nudges, select US patients that initiated herpes zoster vaccination were randomized to receive timed text messages when the second dose was due and available as part of a quality improvement exercise. Main comparisons were between patients intervened by provider nudge only and those intervened by both provider and patient nudges. Data were assessed by GEE-basedlogistic and linear regression, controlling for available patient- and store-level characteristics, and geospatial analyses. RESULTS: During the baseline period, 100,627 adults received at least one HZ vaccine dose and 83.9% completed the series within 6 months over 88.6 days (SD: 26.53) on average. In the intervention period, 120,339 adults were vaccinated at least once and series completion was 88.3% (both provider nudges and text messaging) and 85.3% (not texted) during this observation window (both p < 0.0001). Time between doses was shorter for those who received text messages compared to both the baseline period and those in the intervention period that were not texted (both p < 0.001). Controlling for multiple characteristics, the odds of completion improved in the intervention period compared to baseline (OR: 1.07; 95% CI: 1.033-1.111), but a noticeably higher completion odds was observed amongst patients who received a text message in the intervention period (OR: 1.35; 95% CI: 1.286-1.414). Adjusting for patient and pharmacy factors, those who were texted received their second herpes zoster vaccine dose 8.6 days sooner (95% CI: -9.08 - -8.17, p < 0.0001) compared to those intervened by the provider nudge only. CONCLUSION: The combined use of clinical and patient-focused nudges is a simple mechanism by which pharmacies and other health care access points can address the multi-dose vaccine needs of diverse patient populations.
引用
- Gatwood J, Brookhart A, Kinney O, et al. Impact of patient and provider nudges on addressing herpes zoster vaccine series completion. Vaccine. 2022. PMID: 36526504. doi:10.1016/j.vaccine.2022.12.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。